OCON Medical launches IUD in Europe

Gali Weinreb / Globes     04 April 2017

The Israeli company claims its product is less painful to insert and use than existing non-hormonal IUDs.

OCON Medical, which is developing an intrauterine device (IUD) in a new configuration, has launched its product in Spain and Belgium. OCON Medical founder Dr. Ilan Baram told "Globes" that sales of the product had already topped $1 million in eight countries. In Israel, pharma company Perrigo Company (NYSE:PRGO; TASE:PRGO) has been distributing the product since last August.

OCON's product is round, in contrast to the T-shape of the current devices. The new product is both easier to insert and more flexible, so it does not damage the sides of the womb. The company is conducting a trial of its device in order to prove that it reduces pain, in comparison with the existing products in the market. Meanwhile, IUDs are a growing section of the birth control market.

"Women who do not suffer from severe menstrual bleeding often use a non-hormonal device, and our product is also in this category. At the same time, the current copper devices enhance menstruation and aggravate the pain. Our device does not alter a woman's natural menstruation, and there is a tendency towards reduced bleeding during menstruation. It is also easier to install."

The company began a large-scale trial this year in order to prove its claims. The company says that it has been proven that the round device prevents pregnancy as well as the existing devices, i.e. in 99% of cases.

Over $8 million has been invested in the company to date. Participants in its most recent financing round included Russian fund RNI and a private US investor, in addition to existing investors Pontifax Venture Capital and Docor International.



Corneal inlays need your boost to hit their stride

New help for that bane of middle-age: blurry close-up vision